Plasma-cell-predominant B-cell pseudolymphoma.
A 46-year-old woman with no history of foreign travel presented to the New Jersey Medical School Dermatology Clinic in July, 2007, with pruritic ulcerating facial masses that had been present since October, 2006. Clinical and histopathologic findings were most consistent with a diagnosis of cutaneous plasma cell predominant B cell pseudolymphoma. An extensive search using special stains for an etiologic organism was negative. The term cutaneous pseudolymphoma has been coined to describe the accumulation of either T or B cell lymphocytes in the skin that is caused by a nonmalignant stimulus and encompasses several different terms depending on etiology. In cases of cutaneous pseudolymphoma where a cause is identified, treatment entails removing the underlying causative agent. Idiopathic cases tend to be recalcitrant to treatment.
Nervi
Stephen J
SJ
Department of Dermatology, New York University, USA.
Schwartz
R A
RA
D000038:Abscess / Q000175:diagnosis; D001402:B-Lymphocytes / Q000473:pathology*; D020405:Dermis / Q000473:pathology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003951:Diagnostic Errors; D004804:Eosinophils / Q000473:pathology; D005148:Facial Dermatoses / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D006801:Humans; D007627:Keloid / Q000175:diagnosis; D008875:Middle Aged; D010950:Plasma Cells / Q000473:pathology*; D011537:Pruritus / Q000209:etiology; D019310:Pseudolymphoma / Q000175:diagnosis* / Q000473:pathology; D012883:Skin Ulcer / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology